Survival of VRd vs. Rd in combined overall population. Kaplan-Meier analyses of patients with newly diagnosed MM, evaluating differences in survival between those initially treated with VRd (orange) and those initially treated with Rd (blue), after matching based on stage and PS within each frailty category and combining these for the overall population.